Practical Anticoagulation Strategies for Patients with Cancer
Effective anticoagulation represents a widespread challenge, as it spans tumour types and cancer therapies, yet requires individualised treatment planning. Barriers such as poor team collaboration and concerns regarding drug-drug interactions contribute to the underutilisation of anticoagulation. Together, these challenges underscore the need for education and practical guidance on anticoagulation strategies across clinical scenarios—from patients with cancer who develop atrial fibrillation (AF) and require stroke prevention, to those at risk for cancer-associated venous thromboembolism (VTE).
To address this, ECOS hosted two live webinars featuring a multidisciplinary expert panel and a review of cases provided by the ECOS community.
- Implement evidence-based strategies for preventing stroke in patients with AF and cancer
- Develop individualised plans to prevent and treat cancer-associated VTE based on current guidelines and clinical evidence
- Integrate resources for team collaboration and shared-decision making into anticoagulation treatment planning for patients with cancer